Real-time enrollment status for this uterine cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 12:22 PM UTC
| NCT Number | NCT04814108 |
| Recruiting Status | Recruiting |
| Condition | Uterine Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 76 participants |
| Active Locations | 37 sites in the US |
| Sponsor | K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc |
| Last Updated on CT.gov | November 21, 2024 (Nov 21, 2024) |
As of March 2, 2026: Clinical trial NCT04814108 is currently recruiting participants. This clinical trial study for uterine cancer is actively seeking new participants at 37 locations across the United States. The study is sponsored by K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04814108 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 37 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04814108 was last updated Nov 21, 2024 (November 21, 2024). HelloStudys verifies this status automatically.